A comparative study of effects of antiproliferative drugs on human retinal pigment epithelial cells in vitro

Journal of Ocular Pharmacology and Therapeutics

Volumn 18, Issue 3, 2002, Pages 251-264

  Wu, Wen Chuan ^a   Kao, Ying Hsien ^b   Hu, Dan Ning ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; DAUNORUBICIN; DEXAMETHASONE; FLUOROURACIL; MITOMYCIN; ANTINEOPLASTIC AGENT;

ARTICLE; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PIGMENT EPITHELIUM; VITREORETINOPATHY; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; MICROPHOTOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHOTOMICROGRAPHY; PIGMENT EPITHELIUM OF EYE; VITREORETINOPATHY, PROLIFERATIVE;

EID: 0035990049     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076802760116179     Document Type: Article

References (37)

1. Proliferative vitreoretinopathy: An overview
2. Pathogenic mechanisms in proliferative vitreoretinopathy
3. Proliferative vitreoretinopathy and chemotherapeutic agents
4. Selection of therapeutic agents for intraocular proliferative diseases: Cell culture evaluation
5. Selection of therapeutic agents for intraocular proliferative diseases: Differing antiproliferative activity of the fluoropyrimidines
6. The long-term effects of 5-fluorouracil and sodium butyrate on human Tenon's fibroblasts
7. Ocular cicatricial disease: Drugs effects in vitro on cell proliferation, contraction, and viability
8. Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits
9. Effect of electric pulses and antiproliferative drugs on cultured bovine retinal pigment epithelial cells
10. Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts
11. Cell migration, proliferation, and contraction: An in vitro approach to a clinical problem-proliferative vitreoretinopathy
12. In vitro sensitivity of human Tenon's capsule fibroblasts to mitomycin C and its correlation with outcome of glaucoma filtration surgery
13. Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation
14. Morphology phagocytosis, and vitamin A metabolism of cultured human retinal pigment epithelium
15. Characterization of a novel cationic drug transporter in human retinal pigment cells
16. Isolation and cultivation of human iris pigment epithelium
17. Studies of human uveal melanocytes in vitro: Isolation, purification and cultivation of human uveal melanocytes
18. Retinal pigment epithelial cells in epiretinal membranes: An immunohistochemical study
19. Proliferative vitreoretinopathy membranes: An immunohistochemical study
20. Ultrastructural and electro-immunocytochemical characterization of cells in epiretinal membranes
21. Proliferative vitreoretinopathy: Histopathology of retroretinal membranes
22. Cellular components of subretinal membranes in proliferative vitreoretinopathy
23. Subretinal membranes in proliferative vitreoretinopathy: An immunohistochemical study
24. Culture of retinal pigment epithelial cells from subretinal fluid
25. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation
26. Risk factors for proliferative vitreoretinopathy
27. Fluorouracil for the treatment of massive periretinal proliferation
28. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy
29. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the: Sustained release of fluorouracil
30. Clearance of intravitreal fluorouracil: Normal and aphakic vitrectomized eyes
31. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy
32. Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy
33. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: Results of a multicenter clinical trial
34. Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy
35. Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy
36. Inhibition of intraocular proliferations with intravitreal corticosteroids
37. The mechanism of action of drugs for the treatment of vitreoretinal scarring